Research: NASE

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

Pharmaceutical Business Review

2009-06-26 04:04
Conatus Pharmaceuticals Initiates Second Phase-II Hepatitis Trial
CTS-1027 is an oral, small molecule compound that inhibits the activity of matrix metalloproteinases

2009-06-05 04:03
Genta's Genasense Achieves High Response Rates In Patients With Advanced Melanoma
39% of the patients have achieved major objective responses